title: Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population.
abstract: Homozygous C4A deficiency was found at a prevalence of 16% (13/80 patients) in systemic lupus erythematosus (SLE). The patients represented all diagnosed cases retrieved from a defined population in Southern Sweden, which minimizes the influence of patient selection. Photosensitivity was more common among C4A-deficient patients than among other SLE patients (p less than 0.05). Otherwise, clinical features were similar in the two groups. In addition, no differences were found with regard to presence of various autoantibodies (anti-dsDNA, anti-Sm, anti-RNP, anti-SSA, anti-SSB, rheumatoid factors and anti-cardiolipin). In patients expressing both C4A and C4B isotypes, C4B/C4A quotients were fairly stable in plasma irrespective of disease activity. This argues against preferential break-down of either isotype during complement activation in the disease. The increased photosensitivity of C4A-deficient patients partly resembles the findings in patients with complete deficiencies of classical pathway components.
authors.affiliation: Department of Rheumatology, University Hospital Lund, Sweden.
authors.forename: G
authors.initials: G
authors.lastname: Sturfelt
authors.forename: L
authors.initials: L
authors.lastname: Truedsson
authors.forename: P
authors.initials: P
authors.lastname: Johansen
authors.forename: H
authors.initials: H
authors.lastname: Jonsson
authors.forename: O
authors.initials: O
authors.lastname: Nived
authors.forename: A G
authors.initials: AG
authors.lastname: Sjöholm
mesh_terms: D000974:Antibodies, Antinuclear / Q000032:analysis / Q000235:genetics; D003167:Complement Activation / Q000235:genetics; D015934:Complement C4a / Q000172:deficiency* / Q000235:genetics; D015935:Complement C4b / Q000235:genetics; D005260:Female; D006720:Homozygote; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000235:genetics* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000974:Antibodies, Antinuclear; D015934:Complement C4a; D015935:Complement C4b